Related Experiment Video
Updated: Jun 12, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
[Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina]
Adolfo Rubinstein1, Lisandro Colantonio, Ariel Bardach
1Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina. arubinstein@iecs.org.ar
Insights
Cardiovascular disease burden in Argentina is largely preventable. Modifiable risk factors like hypertension account for significant disease burden and costs, highlighting the need for targeted interventions.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Context:
- Coronary heart disease and stroke represent a significant public health challenge in Argentina.
- Understanding the burden of disease and associated costs is crucial for effective health policy.
- Modifiable cardiovascular risk factors are key targets for intervention.
Purpose:
- To estimate the disease burden, proportion attributable to modifiable risk factors, and hospitalization costs for coronary heart disease and stroke in Argentina.
- To identify the primary modifiable cardiovascular risk factors contributing to this burden.
- To inform public health strategies for cardiovascular disease prevention.
Summary:
- An analytical model using 2005 mortality data identified major modifiable cardiovascular risk factors (hypertension, hypercholesterolemia, obesity, smoking, etc.).
- Over 600,000 years of healthy life lost (YHLL) and 400,000 years of potential life lost (YPLL) were estimated.
- Modifiable risk factors accounted for over 70% of YHLL, YPLL, and hospitalization costs, with hypertension being the most impactful.
Impact:
- The majority of cardiovascular disease burden in Argentina is linked to preventable, modifiable risk factors.
- Population-based and clinical interventions targeting these risk factors can significantly reduce disease burden and costs.
- Cost-effective, accessible, and feasible interventions are available for implementation in Argentina.
Objective:
Estimate the burden of disease, the proportion attributable to the principal modifiable cardiovascular risk factors, and the direct medical cost of hospitalization associated with coronary heart disease and stroke in Argentina.
Methodology:
An analitical model was prepared using Argentina's 2005 mortality data and the prevalence of the principal cardiovascular risk factors (hypertension, hypercholesterolemia, overweight, obesity, hyperglycemia, current and past smoking, sedentary lifestyle, and inadequate intake of fruits and vegetables). The burden of disease-years of potential life lost (YPLL) and years of healthy life lost (YHLL)- and hospitalization costs for the cardiovascular diseases analyzed were estimated.
Results:
In 2005 over 600 000 YHL were lost in Argentina and the number of YPLL due to heart disease and stroke was calculated at 400 000; 71.1% of the YHLL, 73.9% of the YPLL, and 76.0% of the associated costs were attributable to modifiable risk factors. Hypertension was the risk factor with the greatest impact in both men and in women, responsible for 37.3% of the total cost, 37.5% of the YPLL, and 36.6% of the YHLL.
Conclusions:
Most of the burden of disease from cardiovascular disease in Argentina is associated with modifiable, and therefore preventable, risk factors and could be reduced through population-based and clinical interventions that employ a risk approach; such interventions have already proven to be cost effective, accessible, and feasible in countries like Argentina.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease II: Pathophysiology
Bias in Epidemiological Studies
